KRRO-110 miss drives overhaul; KRRO-121/111 show preclinical promise. Click here to read my most recent analysis of the stock ...
Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...
A new study from Google researchers introduces "sufficient context," a novel perspective for understanding and improving retrieval augmented generation (RAG) systems in large language models (LLMs).
NEW YORK, Feb. 23 (UPI) --A new study that compares the label accuracy of a generic drug versus a dietary supplement with the same active pharmaceutical ingredient found that the supplement fared very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results